MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

DownloadDownload image
Non Us$20,335K US$14,638K Non Us$85,442K US$64,797K Pombiliti Opfolda$34,973K Galafold$150,239K Net product sales$185,212K Gross profit$158,665K Cost of goods sold$26,547K Interest income$833K Income (loss) fromoperations$15,946K Total operatingexpenses$142,719K Income (loss) beforeincome tax$3,143K Other (expense)income-$2,208K Interest expense$11,428K Depreciation andamortization$1,897K Selling, general, andadministrative$117,081K Research and development$23,741K Net lossattributable to common...$1,690K Income tax expense$1,453K
Income Statement
source: myfinsight.com
logosdsadsad-svg

AMICUS THERAPEUTICS, INC. (FOLD)

logosdsadsad-svg

AMICUS THERAPEUTICS, INC. (FOLD)